Quantcast
Last updated on April 16, 2014 at 7:25 EDT

Latest Brain tumor Stories

2013-09-27 23:03:30

The Firm is representing cell phone radiation lawsuit plaintiffs who allegedly suffered brain tumors from cell phones. New York, NY (PRWEB) September 27, 2013 As cell phone radiation lawsuits (http://www.consumerinjurylawyers.com/cell-phone-radiation-lawsuit.html) move forward throughout the country, Bernstein Liebhard LLP notes that a new study published in the International Journal of Oncology appears to confirm a link between cell phones and brain tumors that has been seen in previous...

2013-09-24 23:34:41

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a specific protein being found in nearly 100 percent of high-grade meningiomas, suggesting a new target for cancer therapies. New York, NY (PRWEB) September 24, 2013 Voices Against Brain Cancer discusses a specific protein that is being found in nearly 100 percent of high-grade meningiomas, the most common form of brain tumor. According to a September 16, 2013 article published by...

2013-09-24 23:24:42

Nationwide ABTA Survey Drove Development of New Educational Offering for Physicians, Nurses and Social Workers Chicago, IL (PRWEB) September 24, 2013 The American Brain Tumor Association (ABTA), in joint sponsorship with Cleveland Clinic, will present the 15th Annual Brain Tumor Update and 4th Annual International Symposium on Long-term Control of Metastases to the Brain and Spine on Saturday, Nov. 9 and Sunday, Nov. 10 at the Bellagio Hotel in Las Vegas. The first day of the conference...

2013-09-24 12:28:13

Multiple neurosurgical centers to evaluate long-term effectiveness, efficacy, and value of intraoperative MRI for brain tumor surgery MINNEAPOLIS, Sept. 24, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the first brain tumor patient was enrolled by the Washington University School of Medicine, St. Louis, MO, for an expanding clinical neurosurgical database designed to study the use and benefits of ceiling-mounted...

2013-09-24 08:31:21

MD Anderson Cancer Center Orlando Is Now Also Enrolling Patients BETHESDA, Md., Sept. 24, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, announced today that the MD Anderson Cancer Center Orlando has become the second site participating in the Phase I/II clinical trial of DCVax-Direct, the Company's next generation dendritic cell product for the potential...

2013-09-23 16:24:20

GALVESTON, Texas, Sept. 23, 2013 /PRNewswire/ -- Today, Chrysalis BioTherapeutics, Inc., announced receipt of a $1.5m contract from the National Cancer Institute (NCI) to continue its development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. Radiotherapy is a primary tool for controlling tumor growth, yet damage to surrounding normal tissues limit the amount of radiation that can be used to kill tumors. Moreover, side-effects of radiotherapy can have...

2013-09-23 13:14:45

Limiting the amount of radiation absorbed in the hippocampal portion of the brain during whole-brain radiotherapy (WBRT) for brain metastases preserves memory function in patients for up to six months after treatment, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. The single-arm, phase II study was a multi-institutional, international clinical trial in the U.S. and Canada, conducted through the Radiation Therapy...

2013-09-23 13:04:18

When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT. A highly advanced...

2013-09-23 13:02:17

Due to decreased side effects, it may also be cost-saving Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study...

2013-09-23 12:40:17

When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Typically, central nervous system malignancies are treated with surgical resection and post-operative radiation therapy. Proton therapy, an external beam radiation therapy in which protons deliver precise...